Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.4M 19.17M 17.44M 32.78M 2.26B 33.33M 225M 87.84M 1.13B 88.7M 86.77M 3.76B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.43M 34.24M 31.14M 58.54M 4.03B 59.51M 401M 157M 2.02B 158M 155M 6.71B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
09/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
11/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
05/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
14/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+20.00%
Current month+20.00%
1 month+20.00%
3 months-19.23%
6 months-43.24%
Current year+27.27%
1 week 0
Extreme 0.0021
0
1 month 0
Extreme 0.0021
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.69
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+20.00%-36.36%+100.00% 801K
-1.87%-2.33%-27.34%-52.05% 1.92B
-1.52%-5.15% - - 1.77B
-2.67%-13.13%-3.38%+200.84% 1.39B
-1.58%-6.81%-50.67%+39.31% 1.14B
+0.11%+1.43%+195.51%+929.52% 1.12B
-3.80%-5.30%+45.54%+35.83% 957M
-0.56%-26.96%+57.41%+250.18% 950M
+1.80%-13.81%+15.44%+72.67% 885M
+5.51%+6.61%+85.76%-9.39% 732M
Average -0.46%-6.60%+31.32%+174.10% 1.09B
Weighted average by Cap. -0.94%-6.91%+30.56%+175.01%

Financials

2015 2016
Net sales 25.48M 22.01M 20.68M 18.81M 35.36M 2.44B 35.94M 242M 94.74M 1.22B 95.67M 93.59M 4.05B 32.33M 27.92M 26.24M 23.86M 44.86M 3.09B 45.6M 307M 120M 1.55B 121M 119M 5.14B
Net income 5.49M 4.75M 4.46M 4.06M 7.63M 525M 7.75M 52.25M 20.43M 263M 20.63M 20.18M 874M 2.06M 1.78M 1.67M 1.52M 2.86M 197M 2.91M 19.6M 7.66M 98.7M 7.74M 7.57M 328M
Net Debt 24.8M 21.42M 20.13M 18.31M 34.42M 2.37B 34.99M 236M 92.23M 1.19B 93.13M 91.11M 3.95B 18.56M 16.03M 15.06M 13.7M 25.76M 1.77B 26.18M 176M 69.01M 889M 69.68M 68.17M 2.95B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
14/08/26 USD 0.002100 -40.00% 500
13/08/26 USD 0.003500 -.--% 52,661
  1. Stock Market
  2. Stocks
  3. AOXG Stock